Omega Funds global life sciences-based investment firm specialized in direct secondary transactions.
Strategically advanced, they enable you to benefit from the expertise of institutional portfolio managers all for a minimum investment of $500!Omega FundsTM give you the opportunity to diversify your investment portfolio and maximize return potential.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 7, 2021
Scorpion Therapeutics
|
Series B | $162M | Biotechnology | — |
Oct 26, 2020
Scorpion Therapeutics
|
Series A | $108M | Biotechnology | Yes |
Mar 6, 2019
Beam Therapeutics
|
Series B | $135M | Biotechnology | — |
Sep 8, 2017
Replimune Group
|
Series B | $55M | Biotechnology | — |
Sep 24, 2015
Replimune Group
|
Series A | $30M | Biotechnology | Yes |